Dambach Michael E. - 21 Aug 2023 Form 4 Insider Report for BiomX Inc. (PHGE)

Reporting relationship: Director
Issuer ticker: PHGE
Reported as of: 21 Aug 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Aug 2023, 16:01:14 UTC
Prior SEC filing: 19 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Dambach Michael E.

Key filing fact

Dambach Michael E. filed Form 4 for BiomX Inc. (PHGE) on 23 Aug 2023.

Key facts

This page summarizes Dambach Michael E.'s Form 4 filing for BiomX Inc. (PHGE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 Aug 2023, 16:01.

Change

Previous filing in this sequence was filed on 19 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHGE transaction Derivative

Common Stock Options - Right to Buy

Award

Transaction value: $0
Shares: +41,000
Change %
Price: $0.000000
Shares after: 41,000
Date: 21 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 0
Exercise price: $0.3630
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on August 21, 2024, and the remainder vesting in 12 equal quarterly installments over three years.